Pharmacokinetics of KBP-5074 in Patients With Moderate Hepatic Impairment
NCT04534699
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate Hepatic Impairment
Healthy
Interventions
DRUG:
KBP-5074
Sponsor
KBP Biosciences
Collaborators
[object Object]